Study Evaluates Mesenchymal Stem Cell Therapies For Cardiac Patients

Joshua M. Hare, M.D., of the University of Miami Miller School of Medicine, and colleagues conducted a study to examine whether allogeneic (taken from a different individual) mesenchymal stem cells (MSCs) are as safe and effective as autologous (donor and recipient are the same person) MSCs in patients with left ventricular dysfunction due to ischemic cardiomyopathy...

via Medical News Today